Sanofi-Aventis, Merck Unit Sign Cancer Research Agreement - Smart Money

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service91 times read : Adjust font size: Decrease font Enlarge font
image

PARIS -(Dow Jones)- French pharmaceuticals group Sanofi-Aventis (SNY) said Friday that it has signed an agreement with Merck (MRK) division, Merck Serono, to collaborate in specific areas of cancer research. Sanofi's U.S. unit and Merck Serono will ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright